What makes a peptide a specialty research compound?
Specialty is a catalog grouping, not a chemical class. It collects compounds whose studied receptor systems do not fit neatly into the metabolic, growth hormone, healing, cognitive, or melanocortin categories. Gonadorelin and HCG act on the reproductive axis, DSIP is studied in sleep and neuromodulation research, and VIP is a vasoactive intestinal signaling peptide. What they share is that each is characterized in a distinct receptor system with its own literature. The full grouping is listed at /specialty-peptides.
What is Gonadorelin?
Gonadorelin is a synthetic form of gonadotropin-releasing hormone, a decapeptide produced in the hypothalamus. In preclinical research it is characterized as an agonist at the GnRH receptor on pituitary gonadotroph cells, where receptor binding is studied for its role in the release of luteinizing hormone and follicle-stimulating hormone. Because the native hormone is short-lived, published work frequently examines timing and receptor kinetics rather than sustained exposure. Compound detail is at /peptides/gonadorelin. Supplied for laboratory research only.
Why is pulsatile versus continuous GnRH receptor stimulation studied?
This is one of the more instructive receptor findings in the category. Preclinical models report that intermittent stimulation of the GnRH receptor and sustained stimulation produce different downstream patterns, with continuous exposure associated in the literature with receptor desensitization rather than a stronger response. Researchers therefore treat exposure pattern as an experimental variable in its own right, not as a detail of technique. It is a useful reminder that in receptor pharmacology, timing can matter as much as the compound itself.
How does Gonadorelin differ from Kisspeptin in research models?
They sit at different points on the same axis. Kisspeptin is studied as an upstream signal acting on the KISS1R receptor on GnRH neurons, which is one step earlier in the cascade. Gonadorelin acts at the GnRH receptor on the pituitary itself, one step later. That difference is why the two are often compared in reproductive-axis research: they probe the same pathway at different levels. Kisspeptin is catalogued under /sexual-health-peptides, and Gonadorelin under /specialty-peptides.
What is HCG and how is it classified?
HCG, human chorionic gonadotropin, is a glycoprotein hormone rather than a short linear peptide. It is built from two subunits, an alpha subunit shared with several pituitary hormones and a beta subunit that gives it its identity. That structure matters for research handling, because glycoproteins behave differently from small synthetic peptides in terms of stability and analysis. Compound detail is at /peptides/hcg. Research reference material only, not for human or animal consumption.
How does HCG differ from LH at the receptor level?
Both are studied as ligands at the same luteinizing hormone receptor, which is why they appear together in reproductive-axis literature. The commonly reported difference is duration rather than target: preclinical characterization describes HCG as having a substantially longer circulating half-life than LH, so receptor occupancy is studied over a longer window. Researchers comparing the two therefore design different sampling schedules for each. This describes mechanism as characterized in published models, not a clinical comparison.
What is DSIP?
DSIP, or delta sleep-inducing peptide, is a nonapeptide first isolated during sleep research in the 1970s. Its name reflects the observation that gave rise to it, specifically an association with delta-wave activity in early animal models. Despite decades of study, no single receptor has been definitively assigned to it, which makes it unusual in a catalog where most compounds have a named molecular target. Compound detail is at /peptides/dsip. Supplied for laboratory research use only.
What is actually known about the DSIP mechanism?
Less than the name suggests, and that is the honest answer. Published preclinical work has examined possible interactions with neuromodulatory and neuroendocrine systems and has reported findings across a wide spread of endpoints, but a specific high-affinity receptor has not been conclusively identified. Reviews in the field describe the evidence base as fragmentary. Researchers referencing DSIP should treat mechanistic claims about it with more caution than they would apply to a compound with a well-characterized target.
What is VIP?
VIP, vasoactive intestinal peptide, is a 28-amino-acid neuropeptide belonging to the secretin-glucagon structural superfamily, which also contains PACAP, GLP-1, and glucagon. It is widely distributed in the nervous system and the gastrointestinal tract, and preclinical literature examines it across smooth muscle, secretory, and immune-signaling endpoints. That structural family relationship is covered in more depth at /learn/glp1-gip-glucagon-explained. Compound detail is at /peptides/vip.
What are the VPAC1 and VPAC2 receptors?
They are the two principal G-protein-coupled receptors through which VIP signaling is studied, and they are distributed differently across tissues. Because both receptors also bind PACAP with meaningful affinity, receptor selectivity is a central experimental problem in this area rather than a footnote. Studies frequently use selective agonists or antagonists to separate which receptor is responsible for an observed effect. Anyone designing work in this area should expect to control for cross-reactivity between the two.
Why do specialty peptides vary so widely in price?
Because the category is defined by receptor system rather than by structure, it contains compounds of very different manufacturing difficulty. A short synthetic nonapeptide and a two-subunit glycoprotein are not comparable production problems, and price reflects that. Vial size, purity target, and documentation add further spread. The mechanics of how cost is set are covered at /learn/research-peptide-cost-by-category, and current market ranges are listed at /research-peptide-cost.
How should specialty peptides be stored in a research setting?
General laboratory practice for lyophilized peptides applies: keep vials sealed, cold, and shielded from light and moisture until they are needed, and follow the storage guidance supplied with the specific lot. Glycoproteins such as HCG and longer neuropeptides such as VIP are commonly treated as more sensitive to handling than short synthetic sequences. The category-independent handling questions are collected at /questions/storage-and-shelf-life.
How is purity verified for compounds in this category?
The standard evidence is a Certificate of Analysis from third-party testing that confirms both identity and purity for the specific lot, typically using mass spectrometry for identity and HPLC for purity. Identity confirmation matters especially here, because a category that mixes synthetic peptides with glycoproteins is one where an unverified label carries real experimental risk. Testing questions are answered at /questions/purity-testing-and-coa, and lot documentation is available at /coa.
How do researchers calculate concentration after reconstitution?
Concentration is a function of the mass in the vial and the volume of solvent added, so it is arithmetic rather than judgment. Working it out before opening a vial is the practical way to avoid a preparation error that quietly invalidates a result. A calculator for the arithmetic is at /peptide-reconstitution-calculator, and the underlying method is explained at /questions/reconstitution-and-dosing-math. This is laboratory preparation math for in-vitro work, not guidance for any use in humans or animals.
Can these compounds be used in humans or animals?
No. Every compound in this category is supplied as a research reference material for in-vitro and laboratory research use only. None is for human or animal consumption, none is FDA approved, and none is a treatment, supplement, or cosmetic. That framing is not a formality attached to the page, it is the condition under which the material is supplied. Anyone with a health question about any of these substances should consult a licensed clinician rather than a supplier.
Where can researchers find more background on these compounds?
Each compound has its own reference page, reachable from the category listing at /specialty-peptides. Broader background on peptide structure and receptor signaling is at /what-are-peptides and /learn/how-peptides-work-mechanisms. The full library of answer-first topics is at /questions, and longer-form guides are at /learn. Pricing and availability for approved research accounts are handled through /order.
Create a free research account to view current pricing, real-time stock, and bundles, then submit your order for approval.
More research peptide questions
How to Order and Buy Research Peptides: Ordering FAQ · Shipping and Delivery Questions · Purity, Testing, and Certificates of Analysis (COA) · Peptide Reconstitution and Research Dosing Math: Reference FAQ · Research Peptide Storage, Handling, and Shelf Life · Research Peptide Legality, Regulations, and Research-Use Compliance
All questions & answers · What are peptides? · Research guides · Order portal